Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Influenza vaccines: present and future
Peter Palese, Adolfo García-Sastre
Peter Palese, Adolfo García-Sastre
Published July 1, 2002
Citation Information: J Clin Invest. 2002;110(1):9-13. https://doi.org/10.1172/JCI15999.
View: Text | PDF
Perspective Article has an altmetric score of 10

Influenza vaccines: present and future

  • Text
  • PDF
Abstract

Perspective

Authors

Peter Palese, Adolfo García-Sastre

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2002 Total
Citations: 2 2 1 2 1 4 1 4 6 3 2 5 4 1 5 5 8 1 57
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (57)

Title and authors Publication Year
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in QIV vaccinated mice
Jangra S, Lamoot A, Singh G, Laghlali G, Chen Y, Yz T, García-Sastre A, De Geest BG, Schotsaert M
2024
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice.
Jangra S, Lamoot A, Singh G, Laghlali G, Chen Y, Ye T, García-Sastre A, De Geest BG, Schotsaert M
Frontiers in immunology 2024
Influenza Virus Carrying a Codon-Reprogrammed Neuraminidase Gene as a Strategy for Live Attenuated Vaccine.
Dong J, Dong Z, Feng P, Gao Y, Li J, Wang Y, Han L, Li Z, Wang Q, Niu X, Li C, Pan W, Chen L
Human vaccines 2023
Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection
Zykova AA, Blokhina EA, Stepanova LA, Shuklina MA, Ozhereleva OO, Tsybalova LM, Kuprianov VV, Ravin NV
Molecules (Basel, Switzerland) 2023
In silico design of recombinant multi-epitope vaccine against influenza A virus.
Maleki A, Russo G, Parasiliti Palumbo GA, Pappalardo F
BMC bioinformatics 2022
A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines
CL White, K Chiem, DR Perez, J Santos, SC Garcia, A Nogales, L Martínez-Sobrido
Viruses 2021
Efficacy of the commercial plant products acting against influenza-a review.
Brindha Devi A, Sarala R
Future Journal of Pharmaceutical Sciences 2021
A hospital-based nonconcurrent cohort study on factors associated with in-hospital mortality in patients with laboratory confirmed influenza
V Alexander, GJ Paul, A Zachariah, AJ Mathuram
Journal of global infectious diseases 2020
In Vivo Assessment of NS1-Truncated Influenza Virus with a Novel SLSYSINWRH Motif as a Self-Adjuvanting Live Attenuated Vaccine
JM Ngunjiri, A Ali, P Boyaka, PI Marcus, CW Lee, Y Zhou
PloS one 2015
Design of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses
S Shahsavandi, MM Ebrahimi, K Sadeghi, H Mahravani
Virologica Sinica 2015
Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial
RA van Boxtel, P Verdijk, OJ de Boer, E Riet, TT Mensinga, W Luytjes
Human Vaccines & Immunotherapeutics 2015
A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia
R Uraki, Z Piao, Y Akeda, K Iwatsuki-Horimoto, M Kiso, M Ozawa, K Oishi, Y Kawaoka
The Journal of Infectious Diseases 2015
Detection of Influenza A/H1N1-Specific Human IgG-Secreting B Cells in Older Adults by ELISPOT Assay
SD Painter, IH Haralambieva, IG Ovsyannikova, DE Grill, GA Poland
Viral Immunology 2014
Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years
I Almansour, H Chen, S Wang, S Lu
Human Vaccines & Immunotherapeutics 2013
A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges
R Uraki, M Kiso, K Iwatsuki-Horimoto, S Fukuyama, E Takashita, M Ozawa, Y Kawaoka
Journal of virology 2013
Structural Insights on the Potential Significance of the Twin Asn-Residue Found at the Base of the Hemagglutinin 2 Stalk in All Influenza A H1N1 Strains: A Computational Study with Clinical Implications
ME Cueno, K Imai, K Ochiai
OMICS: A Journal of Integrative Biology 2013
Molecular Basis of Live-Attenuated Influenza Virus
W He, W Wang, H Han, L Wang, G Zhang, B Gao, PL Ho
PloS one 2013
A replication-incompetent PB2-knockout influenza A virus vaccine vector
ST Victor, S Watanabe, H Katsura, M Ozawa, Y Kawaoka
Journal of virology 2012
Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine
SC Das, M Hatta, PR Wilker, A Myc, T Hamouda, G Neumann, JR Baker, Y Kawaoka
Vaccine 2012
Epitope specificity of anti-HA2 antibodies induced in humans during influenza infection: Anti-HA2 antibodies after influenza infection of humans
Z Staneková, V Mucha, T Sládková, H Blaškovičová, F Kostolanský, E Varečková
Influenza and Other Respiratory Viruses 2012
“Trivalent influenza vaccination of healthy adults 3 years after the onset of swine-origin H1N1 pandemic: restricted immunogenicity of the new A/H1N1v constituent?”
R Allwinn, M Bickel, C Lassmann, S Wicker, I Friedrichs
Medical Microbiology and Immunology 2012
Use of Praziquantel as an Adjuvant Enhances Protection and Tc-17 Responses to Killed H5N1 Virus Vaccine in Mice
Q Zou, Y Hu, J Xue, X Fan, Y Jin, X Shi, D Meng, X Wang, C Feng, X Xie, Y Zhang, Y Kang, X Liang, B Wu, M Wang, B Wang, Y Guan
PloS one 2012
Sublingual Immunization with a Live Attenuated Influenza A Virus Lacking the Nonstructural Protein 1 Induces Broad Protective Immunity in Mice
HJ Park, B Ferko, YH Byun, JH Song, GY Han, E Roethl, A Egorov, T Muster, B Seong, MN Kweon, M Song, C Czerkinsky, HH Nguyen, PN Boyaka
PloS one 2012
Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus
K Xu, ZY Ling, L Sun, Y Xu, C Bian, Y He, W Lu, Z Chen, B Sun
Viral Immunology 2011
Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner
MP Walkiewicz, D Basu, JJ Jablonski, HM Geysen, DA Engel
The Journal of general virology 2011
A Reassortment-Incompetent Live Attenuated Influenza Virus Vaccine for Protection against Pandemic Virus Strains
R Hai, A Garcia-Sastre, DE Swayne, P Palese
Journal of virology 2011
Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development
Z Staneková, E Varečková
Virology Journal 2010
Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection
BZ Wang, R Xu, FS Quan, SM Kang, L Wang, RW Compans, RA Fouchier
PloS one 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone®) increases antibody response, cellular immunity, and antigenically drifted protection
M Lay, B Callejo, S Chang, DK Hong, DB Lewis, TD Carroll, S Matzinger, L Fritts, CJ Miller, JF Warner, L Liang, J Fairman
Vaccine 2009
The NS1 Protein of a Human Influenza Virus Inhibits Type I Interferon Production and the Induction of Antiviral Responses in Primary Human Dendritic and Respiratory Epithelial Cells
K Haye, S Burmakina, T Moran, A García-Sastre, A Fernandez-Sesma
Journal of virology 2009
Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection
J Mayrhofer, S Coulibaly, A Hessel, GW Holzer, M Schwendinger, P Brühl, M Gerencer, BA Crowe, S Shuo, W Hong, YJ Tan, B Dietrich, N Sabarth, H Savidis-Dacho, O Kistner, PN Barrett, FG Falkner
Journal of virology 2009
Influenza A viruses with truncated NS1 as modified live virus vaccines: Pilot studies of safety and efficacy in horses
Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D, Arkins S, García-Sastre A, Palese P
Equine Veterinary Journal 2009
Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines
CI Yu, M Gallegos, F Marches, G Zurawski, O Ramilo, A García-Sastre, J Banchereau, AK Palucka
Blood 2008
Immunogenetics of seasonal influenza vaccine response
GA Poland, IG Ovsyannikova, RM Jacobson
Vaccine 2008
Heterologous HA DNA vaccine prime—inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses
S Wang, C Parker, J Taaffe, A Solórzano, A García-Sastre, S Lu
Vaccine 2008
Immune Response in the Absence of Neurovirulence in Mice Infected with M Protein Mutant Vesicular Stomatitis Virus
M Ahmed, TR Marino, S Puckett, ND Kock, DS Lyles
Journal of virology 2008
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
O Kistner, MK Howard, M Spruth, W Wodal, P Brühl, M Gerencer, BA Crowe, H Savidis-Dacho, I Livey, M Reiter, I Mayerhofer, C Tauer, L Grillberger, W Mundt, FG Falkner, PN Barrett
Vaccine 2007
Influenza virus evades innate and adaptive immunity via the NS1 protein
A Fernandez-Sesma, S Marukian, BJ Ebersole, D Kaminski, MS Park, T Yuen, SC Sealfon, A García-Sastre, TM Moran
Journal of virology 2006
Longitudinal analysis of genotype distribution of influenza A virus from 2003 to 2005
A Mak, R Rahmanian, V Lei, D Lawrence, M Krajden, RC Brunham, D Skowronski, Y Li, T Booth, SH Goh, M Petric
Journal of clinical microbiology 2006
A simian virus 5 (SV5) P/V mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function
S Arimilli, MA Alexander-Miller, GD Parks
Journal of virology 2006
Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA Vaccines
S Wang, J Taaffe, C Parker, A Solórzano, H Cao, A García-Sastre, S Lu
Journal of virology 2006
Live Attenuated Influenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts
B Ferko, C Kittel, J Romanova, S Sereinig, H Katinger, A Egorov
Journal of virology 2006
Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats
K Karaca, DE Swayne, D Grosenbaugh, M Bublot, A Robles, E Spackman, R Nordgren
Clinical and diagnostic laboratory immunology 2005
Vaccines: past, present and future
SA Plotkin
Nature Medicine 2005
The role of reverse genetics in the development of vaccines against respiratory viruses
GA Marsh, GA Tannock
Expert Opinion on Biological Therapy 2005
Universal Influenza B Vaccine Based on the Maturational Cleavage Site of the Hemagglutinin Precursor
E Bianchi, X Liang, P Ingallinella, M Finotto, MA Chastain, J Fan, TM Fu, HC Song, MS Horton, DC Freed, W Manger, E Wen, L Shi, R Ionescu, C Price, M Wenger, EA Emini, R Cortese, G Ciliberto, JW Shiver, A Pessi
Journal of virology 2005
A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses
IS Lukashevich, J Patterson, R Carrion, D Moshkoff, A Ticer, J Zapata, K Brasky, R Geiger, GB Hubbard, J Bryant, MS Salvato
Journal of virology 2005
Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes
B Ferko, J Stasakova, J Romanova, C Kittel, S Sereinig, H Katinger, A Egorov
Journal of virology 2004
Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina)
CR Baskin, A García-Sastre, TM Tumpey, H Bielefeldt-Ohmann, VS Carter, E Nistal-Villán, MG Katze
Journal of virology 2004
Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors
Y Nakaya, T Nakaya, MS Park, J Cros, J Imanishi, P Palese, A García-Sastre
Journal of virology 2004
Development and evaluation of a real-time nucleic acid sequence based amplification assay for rapid detection of influenza A
C Moore, S Hibbitts, N Owen, SA Corden, G Harrison, J Fox, C Gelder, D Westmoreland
Journal of Medical Virology 2004
PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium
M Bivas-Benita, S Romeijn, HE Junginger, G Borchard
European Journal of Pharmaceutics and Biopharmaceutics 2004
Protective Efficacy of a DNA Influenza Virus Vaccine Is Markedly Increased by the Coadministration of a Schiff Base-Forming Drug
J Charo, JA Lindencrona, LM Carlson, J Hinkula, R Kiessling
Journal of virology 2004
Essential Role of the NV Protein of Novirhabdovirus for Pathogenicity in Rainbow Trout
MI Thoulouze, E Bouguyon, C Carpentier, M Brémont
Journal of virology 2004
Commentary
Hammel JM, Chiang WK
Annals of Emergency Medicine 2004
New directions in vaccine research
Peter Palese, Adolfo Garcia-Sastre
Journal of Clinical Investigation 2002

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Posted by 1 X users
Referenced in 17 patents
23 readers on Mendeley
See more details